SubHero Banner
Text

4th Quarter 2023

Key topics in this quarter’s edition include:

  • Resmetirom for treatment of nonalcoholic steatohepatitis (NASH)
  • Sotatercept for treatment of pulmonary arterial hypertension (PAH)
  • Roluperidone for treatment of negative symptoms associated with schizophrenia

Download PDF

Text